bpc-157 pure delayed release BPC - 250MCG BPC-157 PURE Delayed Release -

Here the honesty caveat has to be explicit

Proposed Mechanisms (Preclinical) BPC-157 Endothelial protection & pro-angiogenic signaling (NO-linked pathways

It is not FDA-approved for human use

While recent incretin-based therapies have provided pharmaceutical inroads into treatment of obesity, there remains an ongoing need for additional medicines with distinct modes of action as independent or complementary therapeutics

BPC-157 can be injected subcutaneously into the abdomen, upper outer thigh, or back of the upper arm for systemic effect

Lyophilization is a dehydration technique in which compounds are frozen and then exposed to low pressure